| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-11 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-10 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-10 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-10 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-10 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-10 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-10 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-10 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-09 |